EICHOR
● Active Not Recruiting
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
Condition: Early Breast Cancer · Sponsor: Hoffmann-La Roche
About this study
This is a Phase III, global, randomized, open-label, multicenter, study evaluating the efficacy and safety of adjuvant giredestrant compared with physician's choice of endocrine therapy in participants with medium- and high-risk Stage I-III histologically confirmed estrogen receptor (ER)-positive and human epidermal growth factor receptor 2 (HER2)-negative early breast cancer.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (622)
| Southern Cancer Center | Daphne, Alabama, United States | — |
| CBCC Global Research Inc., at Comprehensive Blood and Cancer Center | Bakersfield, California, United States | — |
| St Joseph Heritage Healthcare | Fullerton, California, United States | — |
| Long Beach Memorial Medical Center | Long Beach, California, United States | — |
| Cancer Blood and Specialty Clinic | Los Alamitos, California, United States | — |
| The Center for Cancer Prevention and Treatment at St.Joseph Hospital of Orange | Orange, California, United States | — |
| Kaiser Permanente - San Diego | San Diego, California, United States | — |
| Sansum Clinic | Santa Barbara, California, United States | — |
| UCLA Hematology/Oncology | Santa Monica, California, United States | — |
| Torrance Memorial Physician Network/Cancer Care | Torrance, California, United States | — |
| Kaiser Permanente - Vallejo | Vallejo, California, United States | — |
| Rocky Mountain Cancer Centers (Longmont) - USOR | Longmont, Colorado, United States | — |
+ 610 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04961996